Document:

EX-10.5

 Exhibit 10.5 
  

 
 OCLARO TECHNOLOGY LIMITED 

(the “Company”) 
 Caswell,
Towcester, Northamptonshire, NN12 SEQ 
 SUMMARY OF TERMS OF EMPLOYMENT 

This summary of the terms and conditions of employment is provided for ease of reference only and has no legal effect. The terms and conditions applicable to
your employment are set out in the attached contract of employment. In the event that this summary contradicts or differs from the attached contract of employment, the terms and conditions set out in the contract shall prevail and take precedence
over this summary. 
  

			
	 EMPLOY EE’S NAME:
	  	 ADRIAN MELDRUM

	 ADDRESS:
	  	 71 Bishops Drive
 Wokingham

Berks
 RG40 lWA

	
	 Summarv of terms and conditions

		
	 Commencement date:
	  	TBA2013 18/11/13
		
	 NOTICE PERIOD:
	  	Three months or statutory minimum whichever is greater, following completion of the probationary period.
		
	JOB TITLE:	  	EXECUTIVE VICE PRESIDENT WORLDWIDE SALES
		
	REPORTING TO:	  	CHIEF EXECUTIVE OFFICER
		
	PLACE OF WORK:	  	Caswell, but please note that the contract includes a mobility clause.
		
	HOURS OF WORK:	  	VARI-TIME, 37.5 HOURS PER WEEK
		
	SALARY:	  	£170,000 per annum
		
	 BONUS
	  	60% at target with a maximum of 150%. All bonuses are discretionary and subject to Company targets.
		
	 HOLIDAYS:
	  	25 days per calendar year
		
	 SICK PAY:
	  	This is limited to Statutory Sick Pay only for first three months of employment (see note). You will subsequently be eligible for Company sick pay, which includes SSP and varies between 4 weeks to 26 weeks depending on length of
service (with part time staff receiving a pro rata entitlement.)
		
	 PENSION:
	  	The Company will match your contribution plus pay 3% up to a maximum of 9%.
		
	 MEDICAL INSURANCE:
	  	The Company will provide Family cover for you. Cover that includes children will provide insurance for children up to age 24 regardless of whether they are in full time education or
not.

  
 Oclaro CoE Page 1 of 18

			
		
	 MEDICAL CASHPLAN:
	  	The Company will provide Cashplan Level 1 cover for you.
		
	 INCOME PROTECTION:
	  	40% of your salary will be paid as Company sick pay for 5 years (less Single Person’s Incapacity Benefit) following 52 weeks continuous sick absence. This is dependent on acceptance of your application by the scheme
provider.
		
	 LIFE ASSURANCE
	  	This scheme provides benefits on death in service of 4 times your basic annual salary, which is paid in accordance with the rules of the scheme in force.
		
	 AMOUNT OF STOCK
	  	60,000 subject to the conditions stated in this contract.
		
	 OPTION/RSU/RSA:
	  	60,000 subject to the conditions stated in this contract.
		
	 N.B. THERE ARE
  

RESTRICTIONS
  

RELATING TO:
	  	 a) Your use of Confidential Information.
  

b) Your undertaking other employment, engagements and/or having other business interests during your employment with the Company.

 
 c) You being employed, engaged or interested in a competing business for 6 months
following the termination of your employment.
  
 d) You soliciting or dealing with
clients of the Company in competition with the Company’s business for 6 months following the termination of your employment.
  

e) You enticing away or employing any employee of the Company for 6 months following the termination of your employment.

 
 f) You enticing away any supplier of the Company or endeavouring to interfere with the
terms of business between the Company and its suppliers for 6 months following the termination of your employment.
  

g) Your dealing in the shares of the Company.

  
 Oclaro CoE Page 2 of 18

 CONTRACT OF EMPLOYMENT 

This Agreement is dated the * 2013. 
 BETWEEN: 

 

	(1)	OCLARO TECHNOLOGY LIMITED, a company registered in England and Wales under company number 02298887 and with its registered office at Caswell, Towcester, Northamptonshire, NN12 8EQ (the “Company”); and

  

	(2)	Add name and address of employee*. 

  

	1.	JOB TITLE AND DUTIES 

  

	1.1.	You will be employed as Executive Vice President Worldwide Sales, reporting to the Chief Executive Officer, or such other person as the Company may from time to time determine (“your Manager”).

  

	1.2.	You may however be required to carry out such alternative or additional duties as the Company may require from time to time and you agree that you may be seconded to work for one or more Group Companies at any time.

  

	1.3.	You agree to faithfully and diligently perform your duties to the best of your ability and use your best endeavours to promote the interests of the Company and any Group Companies for whom you are required to work.

  

	2.	OUTSIDE INTERESTS 

  

	2.1.	For the purposes of avoiding a conflict of interests with your duties under this agreement, you agree that during your employment you will not be employed, engaged, interested or concerned in any trade, business, firm,
company or organisation without the prior written consent of your Manager. You may, however, hold (directly or through nominees including your spouse, partner or minor children) by way of bona fide personal investment up to 3% of the issued shares,
debentures or other securities of any company whose shares are listed on a recognised investment exchange or dealt in the Alternative Investment Market. 

  

	2.2.	During your employment you will, and will procure that your spouse/partner and minor children will comply with all applicable rules of law, any recognised investment exchange regulations or any Company policy, code or
regulations in relation to dealings in shares, debentures or other securities of the Company and any Group Company or relating to any unpublished price sensitive information affecting the securities of the Company, any Group Company or any other
company. 

  

	3.	FREEDOM TO TAKE UP EMPLOYMENT WITH THE COMPANY 

  

	    	You warrant that any notice period you are required to give or to serve with a previous employer has expired and that, by entering into this contract or performing any of your duties for the Company, you will not be in
breach of any other contract, agreement or obligation binding on you. 

  

	4.	PERIOD OF CONTINUOUS EMPLOYMENT 

  

	    	Your employment will commence on (date). No employment with a previous employer counts as part of your period of continuous employment with the Company 

  
 Oclaro CoE Page 3 of 18

	5.	CONDITIONS OF EMPLOYMENT 

  

	5.1.	Your employment with the Company is conditional on: 

  

	 	(a)	Receipt by the Company of at least two references in relation to you which the Company considers satisfactory, one of which must be from your last employer; and 

 

	 	(b)	You producing such documentation as the Company may reasonably require to establish your right to work lawfully in the United Kingdom. 

 

	5.2.	Should you fail to comply with either of these conditions, any offer of employment by the Company may be withdrawn without notice and if already accepted, the Company may terminate your employment (notwithstanding any
other term of this Agreement) without notice or a payment in lieu of notice during the first month of employment or thereafter by giving you the minimum period of notice required by statute. 

 

	6.	PROBATIONARY PERIOD 

  

	6.1.	The first six months of your employment will be probationary and your performance, conduct and suitability for continued employment will be reviewed throughout this probationary period. 

 

	6.2.	Your employment may be terminated by the Company giving to you not less than one month’s notice at any time during or at the end of the probationary period and you agree that any disciplinary or poor performance
procedures the Company may have in force shall not apply to you during your probationary period. 

  

	7.	TERM 

  

	    	Subject to the remainder of this clause 7, following completion of your probationary period your employment may be terminated by the Company giving to you not less than three months’ written notice.

  

	7.1.	You may terminate your employment at any time by giving to the Company not less than three months’ notice in writing. 

  

	7.2.	Notwithstanding any other term of this Agreement, the Company may terminate your employment without notice and without any payment in lieu of notice in the event that you are guilty of gross misconduct, gross negligence
or breach a fundamental term of this Agreement. 

  

	7.3.	As an alternative to giving you notice in accordance with clause 7.1, the Company may in its absolute discretion choose to terminate your employment immediately at any time provided that the Company will make you a
payment in lieu of notice equivalent to your basic salary over any unexpired period of notice due under clause 7 of this Agreement, subject to deductions for income tax, employee’s national insurance contributions and other deductions required
by law. 

  

	7.4.	You hereby acknowledge and agree that you shall not be entitled to any enhanced redundancy payment(s) in the event that the Company terminates your employment by reason of redundancy at any time, and your entitlement
shall be limited to a statutory redundancy payment calculated in accordance with Section 162 Employment Rights Act 1996 in this event. 

  
 Oclaro CoE Page 4 of 18

	8.	PLACE OF WORK 

  

	    	Your normal place of work will initially be Caswell, Towcester, Northants NN12 8EQ. You agree that the Company may change your normal place of work, temporarily or permanently, to anywhere within the United Kingdom,
even if this requires you to relocate your home. The Company will give you at least one months’ prior notice of any permanent change of location. 

  

	8.1.	If you are required to move your home, the Company will provide you with reasonable relocation assistance. 

  

	8.2.	You may be required to travel and undertake your duties anywhere in the world, provided that you shall not be required to work outside the United Kingdom for periods in excess of one month at a time. 

 

	9.	SALARY 

  

	9.1.	You will be paid a basic salary at a rate of £170,000 (One Hundred and Seventy Thousand pounds} per annum, subject to deductions for income tax, employee’s national insurance contributions and any
other deductions required or permitted by law. Your salary will accrue on a day-to-day basis and is paid on or about 24th day of each month for that complete month. Your salary is paid in respect
of your duties both for the Company and any other Group Company for whom you are required to work. 

  

	10.	EXPENSES 

  

	    	You will be reimbursed for all expenses reasonably and properly incurred by you on the business of the Company or the Group provided you comply with any expenses policy of the Company in force from time to time and you
produce to the Company such receipts, voucher or other evidence of actual payment of the expenses concerned as the Company may reasonably require from time to time. 

 

	11.	PENSION AND OTHER BENEFITS 

  

	    	Pension. You are eligible to join the Company’s Group Personal Pension Plan {GPPP}. The Company will contribute to the GPPP, by means of equal monthly installments, during such periods as you are an
active member of the GPPP at a rate per complete year of membership equivalent to three percent of your base salary more than the personal pension cont ribution you choose to make to the GPPP (with contributions for part of a year being reduced on a
pro rata basis), subject at all times to: (a) a maximum employer contribution per year of nine percent of base salary being payable by the Company; (b) any contribution limitations prescribed by HM Revenue and Customs from time to time; and
(c) the rules of the GPPP (which you acknowledge may vary from time to time) . Contribution levels are outlined in the table below. 

  

					
	 Employee contribution rate
	  	Employer’s
contribution rate	 	Combined contribution rate
	 1%
	  	4%	 	5%
	 2%
	  	5%	 	7%
	 3%
	  	6%	 	9%
	 4%
	  	7%	 	11%
	 5%
	  	8%	 	13%
	 6%
	  	9%	 	15%
	 7% and above
	  	Remains at 9%	 	16% and above dependent on employee
 contribution

  
 Oclaro CoE Page 5 of 18

	    	The Company reserves the right to withdraw this benefit at any time or to vary the rules applicable to the scheme or the level of Company contributions to the scheme. 

 

	11.1.	Private Medical Insurance. 

  

	    	The Company will provide Family cover for you. Cover that includes children will provide insurance for children up to the age of 24 regardless of whether they are in full time education or not. The scheme is provided by
such a reputable medical expenses insurance provider as the Company shall determine from time to time, subject to the Company being able to secure such cover at rates which it determines reasonable. The Company reserves the right to withdraw this
benefit at any time or to vary the terms or level of cover at any time. This is a benefit on which you will be liable to pay income tax. 

  

	11.2.	Medical Cashplan. 

  

	    	The Company will provide Cash plan Level 1 cover for you. This cover includes children to age 18 regardless of whether they are in full time education or not. The scheme is provided by such a reputable Medical Cashplan
expenses insurance provider as the Company shall determine from time to time, subject to the Company being able to secure such cover at rates which it determines to be reasonable. The Company reserves the right to withdraw this benefit at any time
or to vary the terms or level of cover at any time. 

  

	11.3.	Income Protection Insurance. 

  

	    	The Company shall bear the cost of cover for you at rates which are reasonably acceptable to the Company. The Company will provide cover for you under its Income Protection Insurance subject to and in accordance with
the rules and terms of such insurance scheme as may be in force from time to time. If you remain sick for a continuous period of 52 weeks regardless of your length of service you may be entitled to Income Protection Insurance. On acceptance of your
application, 40% your salary will be paid for up to a maximum of 5 years (less Single Person’s Incapacity Benefit). The Company reserves the right to withdraw this benefit at any time or to vary the terms or level of benefits provided by this
cover at any time. 

  

	11.4.	Life Assurance 

  

	    	The Company shall bear the cost of membership of a HMRC approved life assurance scheme for you, subject to and in accordance with the rules and terms of such life assurance scheme as may be in force from time to
time. This scheme provides benefits on death in service of 4 times your basic annual salary, which is paid in accordance with the rules of the scheme in force. The Company reserves the right to withdraw this benefit at any time or to vary the terms
or level of cover at any time. 

  

	11.5.	Stock Options. 

  

	    	Subject to the formal approval of the Board of Directors of Oclaro, Inc. {the “Parent”) and to the terms and conditions stated in the 2004 Amended and Restated Oclaro Stock Incentive Plan and the option
agreement or other documentation governing any grant made to you (together the “Option Documentation”), the Company shall recommend to the Parent that it grants you an option over 60,000 shares of common stock of the Parent at an
option price of not less than the fair market price per share of such common stock on the date of grant {the “Options”). Any Options granted (if any) shall be granted at such time as the Parent shall determine in its absolute discretion
and all Options shall be exercisable and lapse in accordance with the rules of the Option Documentation. 

  
 Oclaro CoE Page 6 of 18

	    	In no circumstances shall you be entitled upon the termination of your employment with the Company to any compensation for any loss of any right or benefit or prospective right or benefit under the Option Documentation
or in respect of any Options, which right or benefit you might have enjoyed if it were not for the termination of your employment (including, without limitation, the lapse of the Options (or part thereof held by you) by reason of the termination of
this agreement or your employment (whether or not such termination is lawful) or your ceasing to be employed by the Company or any Group Company), and regardless whether such compensation is claimed by way of damages for breach of contract or
otherwise. You hereby waive all and any rights you have or may have in the future to any compensation or damages in consequence of the termination of your employment under this agreement or otherwise for any reason whatsoever (including, without
prejudice to the generality of the foregoing, any termination of this agreement by the Company in breach of contract) insofar as those rights arise, or may arise, from your ceasing to have rights under, or be entitled to exercise any Options (or
part thereof) under, the Option Documentation as a result of such termination of your employment or of this agreement or from the loss or diminution in value of such rights or entitlements. 

 

	11.6.	Restricted Stock Unit (RSU/RSA Subject to the formal approval of the Board of Directors of Oclaro, Inc. (the “Parent”) and to the terms and conditions stated in the 2004 Amended and Restated Oclaro
Stock Incentive Plan and the option agreement or other documentation governing any grant made to you (together the “Restricted Stock Documentation”) the Company shall recommend to the Parent that it makes an award of restricted stock to
you with regard to 60,000 [shares of common stock of the Parent] [restricted stock units] (the “Award”). Any Award made (if any) shall be granted at such time as the Parent shall determine in its absolute discretion and the Award shall
vest and be forfeited in accordance with the rules of the Restricted Stock Documentation. 

  

	    	In no circumstances shall you be entitled upon the termination of your employment with the Company to any compensation for any loss of any right or benefit or prospective right or benefit under the Restricted Stock
Documentation or in respect of the Award, which right or benefit you might have enjoyed if it were not for the termination of your employment (including, without limitation, the forfeit of the Award (or part thereof held by you) by reason of the
termination of this agreement or your employment (whether or not such termination is lawful) or your ceasing to be employed by the Company or any Group Company) and regardless whether such compensation is claimed by way of damages for breach of
contract or otherwise. You hereby waive all and any rights you have or may have in the future to any compensation or damages in consequence of the termination of your employment under this agreement or otherwise for any reason whatsoever {including,
without prejudice to the generality of the foregoing, any termination of this agreement by the Company in breach of contract) insofar as those rights arise, or may arise, from your ceasing to have rights under, or be entitled to further vesting of
any Award (or part thereof) under, the Restricted Stock Documentation as a result of such termination of your employment or of this agreement or from the loss or diminution in value of such rights or entitlements. 

 

	12.	HOURS OF WORK 

  

	12.1.	Your normal working hours are 37.5 hours per week. You must work between the hours of 9.30 a .m. to 4.00 p.m. Monday to Friday inclusive provided that you shall be entitled to take between 30 minutes and 2 hours for
lunch each day. You may vary your start time between 7.30 a.m. and 9.30 a.m. and your finish time between 4.00 p.m. and 6.00 p.m. each working day provided that you must work 37.5 hours each week. You may finish early (3.00 p.m.) on a Friday
provided you have worked for 2 hours after lunch and have completed 37.5 hours during the week. You are required to obtain approval from your manager to agree your working hours with your manager. 

  
 Oclaro CoE Page 7 of 18

	12.2.	You may be required to work overtime as required to meet the needs of the business. Your full co-operation is expected at these times . You agree that the limit on average weekly
working time set out in Regulation 4(1) of the Working Time Regulations 1998 will not apply to you, although you may withdraw your consent on giving the Company three months’ prior written notice. 

 

	13.	HOLIDAYS 

  

	13.1.	The Company’s holiday year runs from 1January to 31 December. 

  

	13.2.	You are entitled to 25 days paid holiday entitlement in addition to English public holidays or the equivalent pro rata in each holiday year if you are contracted to work part-time. The holiday entitlement for a
part-time employee will be shown in hours. You are required to save up to four days holiday each year, or the equivalent in hours if you are a part-time employee, each year which shall be taken by you on such days that the Company determines a
shutdown period. Adequate notice will be given by the Site Leader prior to any shutdown, unless you are notified otherwise by the Board in any year. The Company reserves the right to make changes to the amount of days required for a shutdown period
provided that the Company gives you not less than three months’ notice of such changes. 

  

	13.3.	All holiday must be taken at times authorised by your Manager. You should submit requests for leave giving twice as much notice as the period of leave for which you are applying (e.g. if you are applying for one week of
leave, you should apply at least two weeks before the start of the holiday period). For the avoidance of doubt Regulations 15(1) to 15(4) of the Working Time Regulations 1998 will apply to your employment. 

 

	13.4.	You may not, save with the prior express permission of your Manager in writing, carry forward any unused part of your holiday entitlement for a given holiday year into the subsequent holiday year. When permission is
granted, the maximum permitted number of days’ holiday entitlement you may carry forward from any holiday year is limited to five days. This amount will be pro rata and expressed in hours for part-time employees dependent on their contractual
hours. This holiday must be taken by the last day in April of the following year. 

  

	13.5.	For the holiday year during which your employment commences or terminates, your holiday entitlement will be calculated on a pro rata basis according to the number of weeks of completed service in such year.

  

	13.6.	On the termination of your employment with the Company, the Company may at its discretion: 

  

	  	Require you to take, during your notice period, any or all holiday entitlement which will have accrued to you by the date on which your employment terminates; or 

 

	 	(a)	Pay you in lieu of your accrued but unused holiday entitlement, save that, if you are dismissed summarily for gross misconduct, the Company shall be under no obligation to pay you in respect of accrued but untaken
holiday entitlement in excess of any minimum holiday entitlement required by law. All pay in lieu of holiday entitlement will be subject to deductions for income tax, employee’s national insurance contributions and other deductions required by
law; or 

  

	 	(b)	Deduct an amount equal to salary paid to you in respect of holiday taken by you but not accrued by the date on which your employment terminates from any salary or payment in lieu of notice due to you or, in the event
that this is insufficient, require you to repay such an amount to the Company. 

  
 Oclaro CoE Page 8 of 18

	14.	DEDUCTIONS FROM WAGES 

  

	    	Without prejudice to any other rights open to the Company, you agree that the Company may deduct from any wages due to you, (including Company sick pay and any payment in lieu of notice or holiday entitlement) sums
representing the value of any Company property negligently or deliberately lost by you; the cost of repairing any Company property damaged negligently or deliberately by you; any other sums owing from you to the Company; where you have been unable
to perform your duties under this Agreement due to an accident caused by a third party, an amount equal to the amount of any damages you recover from a third party in respect of that accident capped at an amount equal to the salary and benefits you
have received from the Company in respect of any period of absence to which the damages relate; any overpayment of salary or expenses or payment made to you by mistake or through misrepresentation; and any other sums authorised to be deducted by
Section 13 of the Employment Rights Act 1996. 

  

	15.	DATA PROTECTION 

  

	    	In order to keep and maintain any records relating to your employment under this Agreement, it will be necessary for the Company to record, keep and process personal data relating to you on computer and in hard copy
form. (Examples of personal data include details of your disciplinary record, any grievances raised by you and the contents of your personnel file, together with any sensitive personal data held by the Company such as your religious beliefs, your
ethnic or racial origin and information relating to any physical disability or pregnancy). Further in order to pay your salary and offer you the other benefits to which you may be entitled, the Company may also need to obtain from you details of
your bank account and other financial information. To the extent that it is reasonably necessary in connection with your employment and the Company’s responsibilities as an employer, this data may be disclosed to others, including other
employees of the Company or any Group Company, the Company’s professional advisers, the Her Majesty’s Revenue and Customs or other taxation authority, the police and other regulatory authorities. You hereby consent to the recording,
processing, use and disclosure by the Company of personal data relating to you as set out above, including the recording, processing, use and disclosure of your sensitive personal data to the extent required by reason of your employment or by law
and the transmission of such data within or outside the European Union. 

  

	16.	SICKNESS OR INJURY 

  

	16.1.	Your sick absence entitlement includes any right to Statutory Sick Pay for any period of sick absence in line with the prevailing rules of the Statutory Sick Pay scheme and consists of (see note):

  

							
	 Year
	  	Length of service	  	Maximum entitlement in
weeks	  	Level of sick pay
	1	  	0 > 3 months	  	0	  	SSP only
	1	  	3>12 months	  	4	  	Full pay (including SSP)
	2	  	12 > 24 months	  	8	  	Full pay (including SSP)
	3	  	24 > 36 months	  	16	  	Full pay (including SSP)
	4	  	36 > 48 months	  	20	  	Full pay (including SSP)
	5& above	  	48 months & above	  	26	  	Full pay (including SSP)

  

	    	Your entitlement to Company paid sick absence will be based on a rolling twelve month period. This will not affect your right to Statutory Sick Pay for any period of sick absence in line with the prevailing rules of the
Statutory Sick Pay scheme. If you remain sick for a continuous period of 52 weeks regardless of your length of service-you may be entitled to receive benefits under the Company’s Income Protection Insurance. On acceptance of your
application,40% your salary will be paid for 5 years (less Single Person’s Incapacity Benefit) unless during that period you became fit to return to work, subject to the insurer accepting liability for your claim. 

  
 Oclaro CoE Page 9 of 18

	16.2.	If you are absent from work due to sickness, injury or accident you must notify your line manager (or their deputy) as soon as possible and in any event within 30 minutes of your normal start time on the first working
day of absence. You will contact your manager (or their deputy) in person unless you are unable to use the phone. You should not text unless this is a supplementary message. 

 

	16.3.	If you are absent from work for less than 7 days you must complete a Back to Work Form setting out the nature of your illness or incapacity and the date the sickness ended on your return to work. If your absence
continues for more than 7 days you will, on the eighth day of such absence, submit a Fitness To Work Statement from your doctor to your line manager (or their deputy) and continue to submit promptly any additional Statements from your doctor
covering any further period of absence. 

  

	16.4.	Failure to comply with the certification requirements set out above may result in you forfeiting your entitlement to be paid during periods of absence and you may also subject to disciplinary action. Provided you comply
with the notification and certification procedure set out above, during such absence the Company will pay your normal basic salary for the number of weeks specified in 16.1 of this contract, dependent on your length of service at the time of your
sick absence. Thereafter, any Company sick pay is entirely at the discretion of the Company, provided that you shall be entitled to Statutory Sick Pay in accordance with the rules of the Statutory Sick Pay scheme, subject to the Company’s right
to terminate your employment under this Agreement. 

  

	16.5.	Any Company sick pay shall include any Statutory Sick Pay payable to you under the prevailing rules of the Statutory Sick Pay scheme. The Company may deduct from Company sick pay an amount or amounts equal to any state
benefit to which you are entitled. 

  

	16.6.	The Company reserves the right to require you to undergo a medical examination by the Company’s doctor or an independent medical practitioner at any time during a period of absence. You agree that the doctor or
independent medical practitioner may disclose to the Company the results of the examination and discuss with the Company and its professional advisers any matters arising from the examination as might impair you from properly discharging your
duties. The Company may also require you to also authorise your own doctor to provide the Company’s doctor and/or independent medical practitioner with any relevant extracts from your medical notes subject to your rights under the Access to
Medical Reports Act 1988. 

  

	17.	CONFIDENTIALITY 

  

	17.1	During the course of your employment you will have access to and become aware of information which is confidential to the Company. You undertake that you will not, save in the proper performance of your duties for the
Company, disclose to any person, firm, company or organisation or use (whether for your own benefit or for the benefit of any person, firm, company or organisation) any of the trade secrets or other confidential information of or relating to
(a) the Company; (b) any Group Company; (c) any client or customer of the Company; (d) any person, firm, company or organisation with whom or which the Company is involved in any kind of business venture or partnership; or
(e) any other third party to which the Company or any Group Company owes a duty or confidentiality. Further, you agree to use your best endeavours to prevent the unauthorised publication or disclosure of any such trade secrets or confidential
information. 

  
 Oclaro CoE Page 10 of 18

	    	The restriction stated in clause 17.1 above shall apply during, and after the termination of, your employment, but shall cease to apply to information which: 

 

	 	(a)	must be disclosed by law or pursuant to an order of any court or tribunal of competent jurisdiction: 

  

	 	(b)	any information that you can demonstrate to the reasonable satisfaction of the Company came into your knowledge via a third party unrelated to the Company or any Group Company who did not owe any duty of confidentiality
to the Company or relevant Group Company with regard to the applicable information; 

  

	 	(c)	becomes available to the public generally (other than by reason of your breaching this clause). 

  

	 	(d)	Nothing in this clause will prevent you making a “protected disclosure” within the meaning of Sections 43A-L of the Employment Rights Act 1996, provided that you have first followed and exhausted any
reasonable Company procedure in relation to the reporting of any alleged wrongdoing or wrongful conduct on the part of the Company or any Group Company or any of its/their officers, directors, employees or advisers. 

 

	17.2.	For the purposes of this Agreement confidential information shall include, but shall not be limited to:- 

  

	 	(a)	Corporate and marketing strategy and plans and business development plans; 

  

	 	(b)	Budgets, management accounts, bank account details and other confidential financial data; 

  

	 	(c)	Business sales and marketing methods; 

  

	 	(d)	Details, designs, know-how, technical data, techniques, processes and specifications of or relating to any products and services being sold, provided, manufactured, distributed, researched or developed, including all
research and development reports and data and details of intellectual property solutions or rights relating to products or services; 

  

	 	(e)	Methods, procedures and information relating to the operation of its business, including details of salaries, bonuses, commissions and other employment terms applicable; 

 

	 	(f)	The names, addresses and contact details of any Customers or Prospective Customers, including customer lists in whatever medium this information is stored and details in relation to the requirements of those Customers
or the potential requirements of Prospective Customers for any products or services, without prejudice to the generality of the foregoing, information provided by visitors to and users of any of its web sites, 

 

	 	(g)	The terms of business with its advertisers, customers and suppliers, including any pricing policy adopted and the terms of any partnership, joint venture or other form of commercial co-operation or agreement entered
into with any third party; 

  

	 	(h)	Software and technical information necessary for the development, maintenance or operation of any of any website and the source and object code of each website; and 

 

	 	(i)	Any other information in respect of which it is bound by an obligation of confidence owed to a third party. 

  

	17.3.	Your undertaking to the Company in clause 18.1 is given to the Company for itself and as trustee for each Group Company. 

  

	18.	DELIVERY/RETURN OF THE COMPANY’S PROPERTY 

  

	18.1.	You may not save in the proper performance of your duties or with the Company’s permission, remove any property belonging to the Company or any Group Company, or relating to the affairs of the Company or any Group
Company, from the Company’s or any Group Company’s premises, or make any copies of documents or records relating to the Company’s or any Group Company’s affairs. 

  
 Oclaro CoE Page 11 of 18

	18.2.	Upon the Company’s request at any time, and in any event on the termination of your employment, you will immediately deliver up to the Company or its authorised representative, any plans, keys, mobile telephone,
security passes, credit cards, customer lists, price lists, equipment, documents, records, papers, computer disks, tapes or other computer hardware or software (together with all copies of the same), and all property of whatever nature in your
possession or control which belongs to the Company or any Group Company or relates to its or their business affairs. You will at the Company’s request furnish the Company with a written statement confirming that you have complied with this
obligation. 

  

	18.3.	If, on the termination of your employment, you have any information relating to the Company or any Group Company or work you have carried out for the Company or any Group Company which is stored on a device (which for
the purpose of this agreement includes any personal computer, laptop computer, web-server, personal digital assistant, mobile telephone, memory, disk or any other storage medium) which device does not belong to the Company, you agree to disclose
this fact to the Company prior to or immediately upon the termination of your employment and you agree to provide the Company with immediate access to the relevant device so that the Company may download the information and/or supervise its deletion
from the device concerned. 

  

	19.	COPYRIGHT AND DESIGN RIGHTS 

  

	19.1.	You acknowledge and agree that the provisions of this clause 19 apply in respect of any designs, databases, improvements, data, modifications, documents, software, processes, techniques or other things or works
(“Works”) in which any Intellectual Property may subsist that you have made or originated either by yourself or jointly with other people during your employment with the Company or any Group Company including prior to the date of this
agreement (but only to the extent that any such Intellectual Property has not already vested in any Group Company), as well as any such works which you may so make or originate after the date of this agreement (all such Works being “Relevant
Works”). 

  

	19.2.	You will promptly disclose to your line manager all Relevant Works. 

  

	19.3.	Any Work which has been or may be created by you in the normal course of your employment in the course of carrying out duties specifically assigned to you or which is capable of being used or exploited by the Company or
any Group Company in its business operations, shall be the property of the Company whether or not the Work was made at the direction of the Company, or was intended for the Company and the Intellectual Property in and in relation to it shall belong
absolutely to the Company throughout all jurisdictions and in all parts of the world, together with all rights of registration, extensions and renewal (where relevant). 

 

	19.4.	To the extent that such Intellectual Property is not otherwise vested in the Company, you hereby assign, and agree to assign, the same to the Company, together with all past and future rights of action relating thereto.

  

	19.5.	In relation to any Work that may be created by you in the future (but while you remain employed by the Company), whether in the normal course of your employment, in the course of carrying out duties specifically
assigned to you or which is capable of being used or exploited by the Company or any Group Company in its business operations, you hereby assign, by way of present assignment of future rights to the extent permissible by law, the Intellectual
Property in the same to the Company, with the intention that such Intellectual Property should immediately (upon arising vest in the Company. 

  
 Oclaro CoE Page 12 of 18

	19.6.	You recognise and accept that the Company may edit, copy, add to, take from, adapt, alter and translate any Works in exercising the rights assigned under this clause 19. 

 

	19.7.	To the fullest extent permitted by law, you irrevocably and unconditionally waive any provision of law known as “moral rights” including any moral rights you may otherwise have under sections 77 to 85
inclusive of the Copyright Designs and Patents Act 1988 in relation to all Relevant Works. You give this waiver in favour of the Company and each Group Company, and all successors in title to and licensees of any Intellectual Property in such works
(whether existing or future). 

  

	19.8.	You agree that you will at the Company’s request and expense, execute such further documents or deeds and do all things necessary or reasonably requested to vest Intellectual Property in the Company pursuant to,
and/or to confirm and substantiate the rights of the Company under and/or allow Company to enjoy the benefit of, this clause 19 and/or clause 20 both before and after the termination of this agreement for any reason. 

 

	19.9.	You agree that you will not at any time make use of, disclose or exploit any property, trademarks, service marks, documents, materials or information in which the Company or any Group Company owns (wholly or partially)
any Intellectual Property for any purpose which has not been authorised by the Company. 

  

	19.10.	This clause 19 is subject to clause 20 with respect to Inventions and Intellectual Property in inventions. 

  

	20.	INVENTIONS 

  

	20.1.	You acknowledge and agree that the provisions of this clause 20 apply in respect of any invent ion made or discovered or to be made or discovered by you (whether alone or jointly with others) from time to time during
the course of your employment with the Company and any Group Company whether before or after the date of this agreement. 

  

	20.2	It has been and it shall be part of your normal duties at all times to consider in what manner and by what new methods or devices, products, services, processes, equipment or systems of the Company and each Group
Company might be improved and to further the intellectual property interests of the Company. You and the Company agree that, because of the nature of your duties and the particular responsibilities arising from your duties, you have had and continue
to have a special ob ligation to further the interests of the Company. 

  

	20.3.	You hereby acknowledge and agree that the sole ownership of any invention made or discovered or to be made or discovered by you (whether alone or jointly with others) from time to time in the course of undertaking your
normal duties for the Company or any Group Company under this agreement or in the course of carrying out duties assigned to you by the Company or any Group Company under this agreement, whether in each case before or after the date of this agreement
(“Company Inventions”), and all patents and other Intellectual Property there in shall (subject to any contrary provisions of the Patents Act 1977 the Copyright Designs and Patents Act 1988 or any other applicable laws and to any rights of
a joint inventor thereof) belong free of charge and exclusively to the Company or as it may direct. 

  

	20.4.	You shall promptly give to your line manager full details of all inventions made or discovered by you from time to time during your employment with the Company or any Group Company, whether before or after the date of
this agreement. 

  
 Oclaro CoE Page 13 of 18

	20.5.	All Intellectual Property in all Company Inventions shall be and remain the property of the Company and the provisions of clause 19 above shall apply in relation to the same. 

 

	20.6.	You agree that you shall, at any time during your employment or thereafter, at the Company’s expense, do all such acts and things and execute such documents (including without limitation making application for
letters patent) as the Company may reasonably request in order to vest effectually all Company Inventions, to the extent that the same is the property of the Company or any other Group Company, and any protection as to ownership or use (in any part
of the world) of the same, in the Company or any Group Company, or as the Company may direct, and you hereby irrevocably appoint the Company for these purposes to be your attorney in your name and on your behalf to execute and do such acts and
things and execute any such documents as set out above. 

  

	20.7.	You agree that you will not knowingly do or omit to do anything which will or may have the result of imperiling any such protection aforesaid or any application for such protection. 

 

	20.8.	You agree that you will not at any time make use of, disclose or exploit any Company Invention belonging wholly or partially to the Company or any Group Company for any purpose which has not been authorised by the
Company. 

  

	20.9.	Each of the provisions in this clause 20 is distinct and severable from the others and if at any time one or more of such provisions is or becomes invalid, illegal or unenforceable, the validity, legality and
enforceability of the remaining provisions of the clause will not in any way be affected or impaired. 

  

	21.	GARDEN LEAVE 

  

	21.I.	The Company shall be under no obligation to provide you with work during any period of notice to terminate your employment (or any part thereof), whether given by the Company or by you. During such period the Company
may require you: (a) to carry out different duties from your normal duties, whether or not this occasions a loss of status;(b) to cease carrying out your duties altogether;(c) not to attend work and may exclude you from any premises of the
Company or any Group Company; and/or (d) not to have any business dealings or contact with the Company’s employees, suppliers , advertisers, customers, Prospective Customers and agents. You will continue to receive your salary and all
contractual benefits save: (i) where any term of this agreement or any other contract, agreement or plan to which you are a party, or in which you participate, states otherwise; (ii) that any bonus otherwise due to you shall be reduced on
a pro-rata basis to take into account any part of the notice period during which you are on placed on garden leave and suspended from undertaking any duties for the Company; and (iii) that the Company shall have no obligation to compensate you
for any commissions you fail to earn as a result of not actively pursuing your duties for the Company during any part of the notice period during which you are on garden leave and suspended from undertaking any duties for the Company. During such
period of notice, you may not be engaged or employed by or take up any office in any other company, firm, business or organisation or trade on your own account or enter into any partnership without the prior written permission of the Board.

  

	22.	SUSPENSION 

  

	    	The Company may at any time suspend you on full pay pending the outcome of a disciplinary investigation or for health reasons. Whilst you are suspended, the Company may impose the same conditions as apply to garden
leave under clause 21 above. 

  
 Oclaro CoE Page 14 of 18

	23.	RESTRICTIONS AFTER TERMINATION OF EMPLOYMENT 

  

	23.1.	You agree that you will not, without the prior written permission of the Board during the period of 6 months immediately following the termination of your employment ({less any period you spend on garden leave pursuant
to clause 21), whether on your own behalf or on behalf of any individual, company, firm, business or other organisation, directly or indirectly: 

  

	 	(a)	in connection with the carrying on of any business which competes with any business of the Company or any Group Company with which business you were involved in the period of 12 months prior to the termination of your
employment, solicit or entice away from the Company or any Group Company the business or custom of any customer or Prospective Customer with whom you had business dealings on behalf of the Company or any Group Company in the course of the period of
12 months prior to the termination of your employment or about which customer or Prospective Customer you are privy to confidential information at the date your employment terminates; or 

 

	 	(b)	in connection with the carrying on of any business which competes with any business of the Company or any Group Company with which business you were involved in the period of 12 months prior to the termination of your
employment, have business dealings or contract with any Customer or Prospective Customer of the Company or any Group Company with which Customer or Prospective Customer you had business dealings on behalf of the Company or any Group Company in the
course of the period of 12 months prior to the termination of your employment or about which Customer or Prospective Customer you are privy to confidential information at the date your employment terminates; or. 

 

	 	(c)	seek to entice away from the Company or any Group Company any person employed or engaged by the Company or any Group Company as or carrying out the functions of a director, vice president, manager or any other person
acting in a sales, research and development or technical capacity at the date your employment terminates with whom you had material contact in the period of 12 months prior to the termination of your employment with the Company provided that this
restriction shall apply regardless of whether the solicitation involves a breach of contract on the part of the director or employee concerned; or 

  

	 	(d)	employ or engage or offer to employ or engage any person employed or engaged by the Company any Group Company as or carrying out the functions of a Director, Vice President, Manager or any other person acting in a
sales, research and development or technical capacity at the date your employment terminates with whom you had dealings in the last 12 months of your employment with the Company provided that this restriction shall apply regardless of whether the
employment involves a breach of contract on the part of the Director or employee concerned; or 

  

	 	(e)	endeavour to entice away from the Company or in any way seek to affect the terms of business on which the Company deals with any person, firm, company or organisation whom or which supplied goods or services to the
Company during the period of 12 months prior to the termination of your employment. 

  

	23.2.	You agree that you will not, without the prior written permission of the Board, for a period of 6 months following the termination of your employment with the Company (less any period you spend on garden leave pursuant
to clause 21), be engaged or employed in the Restricted Area by or otherwise involved or interested in any company, firm, organisation or business which competes in the Restricted Area with any business of the Company or any Group Company with which
business you are involved in the last 12 months of your employment under this Agreement. 

  

	23.3.	Each of the sub-clauses contained in clause 23 constitutes an entirely separate and independent covenant. If any restriction is held to be invalid or unenforceable by a court of competent jurisdiction, it is intended
and understood by the parties that such invalidity or unenforceability will not affect the remaining restrictions or the validity of the rest of the Agreement and that if any such restriction would be valid if some part thereof were deleted, such
restrictions shall apply with such modification as may be necessary to make them effective. 

  
 Oclaro CoE Page 15 of 18

	23.4.	You agree that if you receive an offer of employment, consultancy, directorship or other office or partnership during the continuance in force of any of the above, you will prior to acceptance of an offer, provide the
party making the offer with copies of this clause and details of your notice period, the restrictions on your use and disclosure of confidential information and the clauses dealing with copyright and inventions. Further, within 48 hours of receiving
the aforementioned offer you will notify the Company of the identity of the party making the offer and the terms of the offer. 

  

	23.5.	You acknowledge that:- 

  

	 	(a)	Each of the restrictions in clause 23 goes no further than is necessary to protect the legitimate business interests of the Company and any Group Company; and 

 

	 	(b)	The Company is entering into this Agreement not only for itself but as trustee for each Group Company and with the intention that the Company and/or any Group Company will be entitled to seek the protection of and
enforce each of its restrictions directly against you. If requested to do so by the Company however, you will at any time enter into like restrictions as those contained in this clause 24 (mutatis mutandis) with any other Group Company.

  

	23.6.	Nothing in this clause 23 shall prohibit you from holding the investments and interests set out in clause 2.1 above. 

  

	23.7.	Following the date your employment terminates, you will not: 

  

	 	(a)	represent yourself as being in any way connected with the business of the Company or any Group Company (except to the extent agreed by such Company): 

 

	 	(b)	represent, promote or advertise or refer to your previous connection with the Company or any Group Company in such a way as to utilise any of their goodwill 

 

	 	(c)	carry on, cause or permit to be carried on any business under or using any name, trade mark, service mark, style, logo, get-up or image which is or has been used by the Company or any Group Company, or which in the
reasonable opinion of the Board, is calculated to cause confusion with such a name, trade mark, service mark, style, logo, get-up or image or infer a connection with the Company or any Group Company. 

 

	24.	DISCIPLINARY AND GRIEVANCE PROCEDURES 

  

	    	A copy of the Company’s disciplinary and grievance procedures are available from Human Resources. These policies do not form part of your contract of employment and may be varied by the Company at any time.

  

	25.	COLLECTIVE AGREEMENTS 

  

	    	There are no Collective Agreements which directly affect your terms and conditions of employment. 

  

	26.	SECURITY 

  

	26.1.	All communications, whether by telephone, email, fax, or any other means, which are transmitted, undertaken or received using Company property or on Company premises will be treated by the Company as work related and
are subject to interception, recording and monitoring without further notice. You should not regard any such communications as private. 

  

	26.2.	Interception, recording and monitoring of communications is intended to protect the Company’s business interests, for example, but without limitation, for the purposes of quality control, security of communication
and IT systems, record-keeping and evidential requirements, detection and prevention of criminal activity or misconduct and to assist the Company to comply with relevant legal requirements. Such interception, recording and monitoring will not be
undertaken for prurient interest. 

  
 Oclaro CoE Page 16 of 18

	26.3.	Intercepted communications may be used as evidence in disciplinary or legal proceedings, including in any such action against you. 

  

	26.4.	By transmitting, undertaking or receiving communication using Company property or on Company premises you consent to the above terms. 

 

	27.	ENTIRE AGREEMENT 

  

	27.1.	This Agreement sets out the entire agreement between the Company and you at the date of this Agreement in relation to your terms and conditions of employment and is in substitution for and supersedes any previous
contract of employment between the Company and you, which shall be deemed to have been terminated by mutual consent and without giving rise to claims against the Company. You represent and warrant that you are not entering into this Agreement in
reliance on any representation not expressly set out herein. 

  

	27.2.	The termination of this Agreement howsoever arising shall not affect any of the provisions of this Agreement which are expressed to operate or have effect or are capable of operation or effect after such termination.

  

	28.	NOTICES 

  

	    	Any notice you are required to give under this Agreement should be given by you to your Manager. Any notice the Company is required to give you should be handed to you or delivered or posted by special delivery post to
your last notified address. These notices will be deemed to have been given on receipt if handed to you or your Manager, when delivered if delivered or posted to your last notified address. 

 

	29.	THIRD PARTIES 

  

	    	This Agreement constitutes an agreement solely between the Company and you and, save where otherwise provided, nothing in this contract confers or purports to confer on a third party any benefit or any right to enforce
a term of this contract for the purposes of the Contracts (Rights of Third Parties) Act 1999. 

  

	30.	INTERPRETATION 

  

	    	Any reference in this Agreement to:- 

  

	30.1.	Any Act or delegated legislation includes any statutory modification or re-enactment of it or the provision referred to; 

  

	30.2.	“Board” shall mean the Board of Directors of the Company from time to time or any person or any committee of the Board duly appointed by it; 

 

	30.3.	“Group Company” means a company which from time to time is a subsidiary or a holding company of the Company or a subsidiary of such holding company (where the terms “subsidiary” and “holding
company” have the meanings attributed to them by section 1159 of the Companies Act 2006); 

  

	30.4.	“include” and “including” and “in particular” shall be construed as being by way of illustration only and shall not limit the generality of the preceding words; 

 

	30.5.	“Intellectual Property” means rights in designs, copyrights and related rights, patents, rights in confidential information (including know-how), trade mark rights and database rights, in each case whether or
not registered or registrable and including applications (and rights to apply) for registration, and all rights and forms of protection of a similar nature or having equivalent effect subsisting from time to time in any jurisdiction worldwide;

  
 Oclaro CoE Page 17 of 18

	30.6.	“Prospective Customer” means any person with whom the Company (or any Group Company) is in negotiations or is tendering for the supply of its goods and services; and 

 

	30.7.	“Restricted Area” means England and such other countries within which, on the date your employment terminates, the Company or any Group Company operates the business within which you were employed by the
Company during the last 12 months of your employment with the Company and in relation to which country, during the last 12 months of your employment, you: 

  

	 	(a)	undertook material duties for the Company or any Group Company in relation to any part of the Business being operated in that country; or 

 

	 	(b)	had a material degree of management responsibility for a material part of the Business being operated in that country; or 

  

	 	(c)	were privy to confidential information relating to the Business . 

  

	31.	GOVERNING LAW 

  

	    	Your terms of employment with the Company are governed by English law and the parties submit to the exclusive jurisdiction of the English Courts. The Company may however enforce the Agreement in any other courts of
competent jurisdiction. 

 IN WITNESS WHEREOF this agreement has been executed by an authorised employee of the Company, and executed and
delivered as a deed by you, on the date stated on the first page of this agreement. 
  

			
	EXECUTED by Oclaro Technology Limited:	  	/s/ ELAINE BARNDEN
		  	Elaine Barnden, Senior HR Director EMEA
		
	EXECUTED and DELIVERED as a DEED	  	
	By Adrian Meldrum:	  	/s/ ADRIAN MELDRUM
		
	  
 in the presence of:-
	  	
		
	Signature of witness	  	/s/ STEPHEN SHAW
	Name of witness	  	Stephen Shaw
	Address of witness	  	 79 Bishops Drive
 Wokingham

RG40 lWA

		
	Occupation of witness	  	IT Consultant

  
 Oclaro CoE Page 18 of 18EX-10.6

 Exhibit 10.6 

OCLARO, INC. 
 EXECUTIVE
SEVERANCE AND RETENTION AGREEMENT 
 THIS EXECUTIVE SEVERANCE AND RETENTION AGREEMENT by and between Oclaro, Inc., a Delaware corporation
(the “Company”), Oclaro Technology Limited, a company registered in England under registered number 02298887 (the “Subsidiary”) and Adrian Meldrum (the “Executive”) is made as of 18th November 2013 (the “Effective Date”). 
 WHEREAS, the Company, the Subsidiary
and Executive wish to provide for agreed­ upon severance arrangements in the event that the Executive ceases to be an employee of the Subsidiary under certain circumstances prior to any change in control of the Company, 

WHEREAS, the Company also recognizes that, as is the case with many publicly-held corporations, the possibility of a change in control of the
Company exists and that such possibility, and the uncertainty and questions which it may raise among key personnel, may result in the departure or distraction of key personnel to the detriment of the Company, the Subsidiary and the Company's
stockholders, and 
 WHEREAS, the Compensation Committee of the Board of Directors of the Company (the “Board”) has determined
that appropriate steps should be taken to reinforce and encourage the continued employment and dedication of the key personnel of the Company and the Subsidiary without distraction from the possibility of termination under certain circumstances or a
change in control of the Company and related events and circumstances. 
 NOW, THEREFORE, as an inducement for and in consideration of the
Executive remaining in the employ of the Subsidiary, the Company and the Subsidiary agree that the Executive shall receive the severance benefits set forth in this Agreement under the terms and subject to the provisions, provided below. 

1. Key Definitions. 
 As used
herein, the following terms shall have the following respective meanings: 
 1.1 “Cause” means: 

(a) the Executive’s willful and continued failure to substantially perform Executive’s reasonable assigned duties as
an employee of the Company and/or the Subsidiary (other than any such failure resulting from incapacity due to physical or mental illness or any failure after the Executive gives notice of termination for Good Reason), which failure is not cured
within 30 days after a written demand for substantial performance is received by the Executive from the Board that specifically identifies the manner in which the Board believes the Executive has not substantially performed the Executive’s
duties; provided that, for purposes of Section 3.1, for all Executives other than the Chief Executive Officer of the Company (“CEO”), substantial performance shall be determined by the CEO and such written demand for
substantial performance shall be provided by the CEO; or 

 (b) the Executive’s willful engagement in illegal conduct or gross
misconduct which is materially and demonstrably injurious to the Company and/or the Subsidiary. 
 For purposes of this Section 1.1, no
act or failure to act by the Executive shall be considered “willful” unless it is done, or omitted to be done, in bad faith and without reasonable belief that the Executive’s action or omission was in the best interests of the Company
or the Subsidiary. 
 1.2 “Change in Control” means an event or occurrence set forth in any one or more of
subsections (a) through (d) below (including an event or occurrence that constitutes a Change in Control under one of such subsections but is specifically exempted from another such subsection): 

(a) the acquisition by an individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the
Securities Exchange Act of 1934, as amended (the “Exchange Act”)) (a “Person”) of beneficial ownership of any capital stock of the Company if, after such acquisition, such Person beneficially owns (within the meaning of Rule
13d-3 promulgated under the Exchange Act) 50% or more of either (x) the then-outstanding shares of common stock of the Company (the “Outstanding Company Common Stock”) or (y) the combined voting power of the then-outstanding
securities of the Company entitled to vote generally in the election of directors (the “Outstanding Company Voting Securities”); provided, however, that for purposes of this subsection (a), the following acquisitions shall not
constitute a Change in Control: (i) any acquisition directly from the Company (excluding an acquisition pursuant to the exercise, conversion or exchange of any security exercisable for, convertible into or exchangeable for common stock or
voting securities of the Company, unless the Person exercising, converting or exchanging such security acquired such security directly from the Company or an underwriter or agent of the Company), (ii) any acquisition by the Company,
(iii) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or any corporation controlled by the Company, or (iv) any acquisition by any corporation pursuant to a transaction which complies
with clauses (i) and (ii) of subsection (c) of this Section 1.2; or 
 (b) such time as the Continuing
Directors (as defined below) such time as the Continuing Directors (as defined below) do not constitute a majority of the Board (or, if applicable, the Board of Directors of a successor corporation to the Company), where the term “Continuing
Director” means at any date a member of the Board (i) who was a member of the Board on the date of the execution of this Agreement or (ii) who was nominated or elected subsequent to such date by at least a majority of the directors
who were Continuing Directors at the time of such nomination or election or whose election to the Board was recommended or endorsed by at least a majority of the directors who were Continuing Directors at the time of such nomination or election;
provided, however, that there shall be excluded from this clause (ii) any individual whose initial assumption of office occurred as a result of an actual or threatened election contest with respect to the election or removal of directors
or other actual or threatened solicitation of proxies or consents, by or on behalf of a person other than the Board; or 

  
 -2- 

 (c) the consummation of a merger, consolidation, reorganization,
recapitalization or statutory share exchange involving the Company or a sale or other disposition of all or substantially all of the assets of the Company in one or a series of transactions (a “Business Combination”), unless, immediately
following such Business Combination, each of the following two conditions is satisfied: (i) all or substantially all of the individuals and entities who were the beneficial owners of the Outstanding Company Common Stock and Outstanding Company
Voting Securities immediately prior to such Business Combination beneficially own, directly or indirectly, more than 50% of the then-outstanding shares of common stock and the combined voting power of the then-outstanding securities entitled to vote
generally in the election of directors, respectively, of the resulting or acquiring corporation in such Business Combination (which shall include, without limitation, a corporation which as a result of such transaction owns the Company or
substantially all of the Company’s assets either directly or through one or more subsidiaries) (such resulting or acquiring corporation is referred to herein as the “Acquiring Corporation”) in substantially the same proportions as
their ownership, immediately prior to such Business Combination, of the Outstanding Company Common Stock and Outstanding Company Voting Securities, respectively; and (ii) no Person (excluding any employee benefit plan (or related trust)
maintained or sponsored by the Company or by the Acquiring Corporation) beneficially owns, directly or indirectly, 30% or more of the then outstanding shares of common stock of the Acquiring Corporation, or of the combined voting power of the
then-outstanding securities of such corporation entitled to vote generally in the election of directors (except to the extent that such ownership existed prior to the Business Combination); or 

(d) approval by the stockholders of the Company of a complete liquidation or dissolution of the Company. 

1.3 “Change in Control Date” means the first date during the Term (as defined in Section 2) on which a
Change in Control occurs. Anything in this Agreement to the contrary notwithstanding, if (a) a Change in Control occurs, (b) the Executive’s employment with the Subsidiary is terminated prior to the date on which the Change in Control
occurs, and (c) it is reasonably demonstrated by the Executive that such termination of employment (i) was at the request of a third party who has taken steps reasonably calculated to effect a Change in Control or (ii) otherwise arose
in connection with or in anticipation of a Change in Control, then for all purposes of this Agreement the “Change in Control Date” shall mean the date immediately prior to the date of such termination of employment. 

1.4 “Disability” means the Executive’s incapacity due to mental or physical illness which is determined
to be total and permanent by a physician selected by the Company or the insurers of the Company or the Subsidiary and acceptable to the Executive or the Executive’s legal representative. Notwithstanding anything to the contrary herein, for
purposes of this Agreement, each reference to the Subsidiary’s termination of the Executive’s employment without Cause shall be deemed to exclude the Subsidiary’s termination of the Executive’s employment by reason of his or her
Disability. 

  
 -3- 

 1.5 “Good Reason” means the occurrence, without the
Executive’s written consent, of any of the events or circumstances set forth in clauses (a) through (d) below. 

(a) a material diminution in the Executive’s authority, duties or responsibilities as in effect immediately prior to the
earliest to occur of (i) the Change in Control Date, (ii) the date of the execution by the Company of the definitive 

written agreement or instrument providing for the Change in Control or (iii) the date of the adoption by the Board of a
resolution providing for a Change in Control (with the earliest to occur of such dates referred to herein as the “Measurement Date”); 

(b) a material diminution in the Executive’s base compensation as in effect on the Measurement Date or as the same may be
increased from time to time thereafter; 
 (c) a change by the Subsidiary in the location at which the Executive performs
Executive’s principal duties for the Subsidiary to a new location that is both (i) outside a radius of 35 miles from the Executive’s principal residence immediately prior to the Measurement Date and (ii) more than 20 miles from
the location at which the Executive performed Executive’s principal duties for the Subsidiary immediately prior to the Measurement Date; or 

(d) any other action or inaction that constitutes a material breach by the Company of this Agreement. 

2. Term of Agreement. This Agreement, and all rights and obligations of the pcu1ies hereunder, shall take effect upon the Effective Date and
shall expire upon the first to occur of (a) the expiration of the Term (as defined below) if a Change in Control has not occurred during the Term, (b) the termination of the Executive’s employment with the Subsidiary prior to the
expiration of the Term, other than by reason of a termination by the Subsidiary without Cause or a termination of the Executive’s employment by reason of a Disability prior to the occurrence of a Change in Control, (c) the fulfillment by
the Company and the Subsidiary of all of its respective obligations under Section 3 if the Executive’s employment with the Subsidiary is terminated without Cause prior to a Change in Control, (d) the date 12 months after the Change in
Control Date, if the Executive is still employed by the Subsidiary as of such later date, or (e) the fulfillment by the Company and the Subsidiary of all of its obligations under Section 4 if the Executive’s employment with the
Subsidiary terminates within 12 months following the Change in Control Date. “Term” shall mean the period commencing as of the Effective Date and continuing in effect through December 31, 2014. 

3. Benefits Prior to a Change in Control. 

3.1 Termination of Employment Without Cause or Upon Death. Subject to the terms and conditions set forth in Section 5, in
the event that the Executive’s employment is terminated because of the death of the Executive or by the Subsidiary without Cause at any time prior to a Change in Control (such date of termination or death, the “Section 3 Date of
Termination”), the Executive (or Executive’s heirs) shall be entitled to the following aggregate benefits: 

  
 -4- 

 (a) The sum of (i) an amount equal to the average of the Executive’s
bonuses earned during the last 3 full fiscal years (or such lesser number of years in which the Executive earned a bonus), (“Average Bonus”) divided by 2, with the resulting amount multiplied by a fraction, the numerator of which is the
number of days preceding the Section 3 Date of Termination in the current bonus period and the denominator of which is the total number of days in the current bonus period (the “Pro-Rata Bonus”), (ii) any prior period bonus
approved by the Board or the Compensation Committee of the Board but not paid, (iii) the amount of any accrued base salary and/or vacation pay to the Section 3 Date of Termination, in each case to the extent not previously paid (the sum of
the amounts described in clauses (ii) and (iii) shall be herein referred to as “Accrued Obligations”), payable in a lump sum in cash within 55 days following the Section 3 Date of Termination; and 

(b) An amount, capped at 1.5 times the Executive’s base salary then in effect, equal to (i) Executive’s annual
base salary then in effect multiplied by 0.67, plus (ii) one (1) month of the Executive’s monthly base salary then in effect for each whole year of the Executive’s employment by the Subsidiary, as measured from the Section 3
Date of Termination (the “Section 3 Termination Payment Period”), which amount shall be paid as a lump sum cash payment within 55 days following the Section 3 Date of Termination (subject to Section 3.2 below). Existing option,
restricted stock and other equity awards will continue to be governed by the terms of their respective grants and plan provisions. 

For the avoidance of doubt, the bonus shall be determined by (a) including bonuses earned for the prior three fiscal years,
regardless of whether such bonus amounts were paid during such fiscal year or in the following fiscal year and (b) excluding any bonus amount paid during any of such three fiscal years that was earned for any fiscal year prior to such three
fiscal years. 
 3.2 Release. The payment to the Executive (or Executive’s heirs) of the amounts and benefits payable
under Sections 3.l(a)(i) and 3.l(b) shall be contingent upon both (i) the execution by the Executive (or Executive’s heirs) of a compromise agreement and release in a form reasonably acceptable to the Company and substantially as set forth
in Exhibit A to this Agreement (the “Executive Release”) and upon the Executive Release becoming effective and irrevocable in accordance with its terms within 55 days following the Section 3 Date of Termination,
and upon the Executive’s independent legal adviser providing a signed solicitor’s certificate in the form reasonably acceptable to the Company; and (ii) agreement by the Executive to standard confidentiality obligations, a non­
solicitation of the customers of the Company and/or the Subsidiary for six-months following the Section 3 Date of Termination and a non-solicitation of the employees of the Company or of the Subsidiary for twelve-months following the
Section 3 Date of Termination, provided that the Executive signs such agreement by the 55th day following his or her Section 3 Date of Termination. Executive will be given a 21 day period to review and consider the Executive Release (such
period may be extended to 45 days if required under applicable law) and the Executive may revoke the release for a period of 7 days, during which time the release shall not become effective or enforceable until the revocation period has expired.

  
 -5- 

 3.3 Sole Remedy. The payments under this Section 3 constitute the
sole remedy of the Executive as a result of the circumstances set forth in this Section 3. 
 4. Benefits after a Change in Control.

 4.1 Termination of Employment. 

(a) If the Change in Control Date occurs during the Term, any termination of the Executive’s employment by the Subsidiary
or by the Executive within 12 months following the Change in Control Date or termination due to the Executive’s death within 12 months following the Change in Control Date, shall be communicated by a written notice to the other party hereto
(the “Notice of Termination”), given in accordance with Section 8. Any Notice of Termination shall: (i) indicate the specific termination provision (if any) of this Agreement relied upon by the party giving such notice, (ii) to
the extent applicable, set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Executive’s employment under the provision so indicated and (iii) specify the Date of Termination (as
defined below). The effective date of an employment termination (the “Date of Termination”) shall be (I) the close of business on the date specified in the Notice of Termination (which date may not be more than 45 days after the date
of delivery of such Notice of Termination or such longer period as may be required by applicable law) or (IO the date of the Executive’s death. 

(b) The failure by the Executive, the Subsidiary or the Company to set forth in the Notice of Termination any fact or
circumstance which contributes to a showing of Good Reason or Cause shall not waive any right of the Executive, the Subsidiary or the Company, respectively, hereunder or preclude the Executive, the Subsidiary or the Company, respectively, from
asserting any such fact or circumstance in enforcing the Executive’s, the Subsidiary’s or the Company’s rights hereunder. 

(c) Any Notice of Termination for Cause given by the Company or the Subsidiary must be given within 90 days of the occurrence
of the event(s) or circumstance(s) which constitute(s) Cause. Prior to any Notice of Termination for Cause being given (and prior to any termination for Cause being effective), the Executive shall be entitled to a hearing before the Board at which
the Executive may, at the Executive’s election, be represented by legal counsel and at which Executive shall have a reasonable opportunity to be heard. Such hearing shall be held on not less than 15 days prior written notice to the Executive
stating the Board’s intention to terminate the employment of the Executive for Cause and stating in detail the particular event(s) or circumstance(s) which the Board believes constitutes Cause for termination. 

  
 -6- 

 (d) Any Notice of Termination for Good Reason given by the Executive must be
given within 90 days of the occurrence of the event(s) or circumstance(s) that constitute(s) Good Reason. Notwithstanding the foregoing, such occurrence shall not be deemed to constitute Good Reason unless (i) within 30 days of the receipt by
the Company or the Subsidiary of the Notice of Termination , such event or circumstance has not been fully corrected and the Executive has not been reasonably compensated for any losses or damages resulting there from and (ii) the
Executive’s Date of Termination occurs within two years following the Company’s receipt of the Notice of Termination. 

4.2 Benefits to Executive. 

4.2.1. Stock Acceleration. For each equity award (including options and other awards) granted to the Executive prior to
the Effective Date, if the Change in Control Date occurs during the Term, then, effective upon the Change in Control Date, (a) each outstanding option to purchase shares of Common Stock of the Company held by the Executive (or Executive’s
heirs) shall become immediately exercisable in full, (b) each outstanding restricted stock award (“RS”) or restricted stock unit (“RSU”) shall be deemed to be fully vested and, for RSUs, the shares of Company Stock will be
delivered upon vesting and (c) notwithstanding any provision in any applicable option agreement to the contrary, each such option shall continue to be exercisable by the Executive (to the extent such option was exercisable on the Date of
Termination) until the earlier of (i) a period of six months following the Date of Termination and (ii) the original expiration date of such option. 

For each equity award (including options and other awards) granted to the Executive after the Effective Date and prior to the
Change in Control Date, if the Change in Control Date occurs during the Term and the Date of Termination occurs within 12 months following the Change in Control Date due to death, a termination without Cause or a termination for Good Reason, then,
effective upon the Date of Termination, (a) each outstanding option to purchase shares of Common Stock of the Company held by the Executive (or Executive’s heirs) shall become immediately exercisable in full, (b) each outstanding
restricted stock award or RSU shall be deemed to be fully vested and, for RSUs, the shares of Company Stock will be delivered upon vesting and (c) notwithstanding any provision in any applicable option agreement to the contrary, each such
option shall continue to be exercisable by the Executive (to the extent such option was exercisable on the Date of Termination) until the earlier of (i) a period of twelve months following the Date of Termination and (ii) the original
expiration date of such option. 
 4.2.2 Compensation. If the Change in Control Date occurs during the Term and the
Executive’s employment with the Subsidiary terminates within 12 months following the Change in Control Date, the Executive shall be entitled to the following additional benefits: 

  
 -7- 

 (a) Termination Upon Death, Without Cause or for Good Reason. Subject to
the terms and conditions set forth in Sections 4.4 and 5, if the Executive’s employment with the Subsidiary is terminated (i) because of the death of the Executive or (ii) by the Subsidiary (other than for Cause or by reason of the
Executive’s Disability) or by the Executive for Good Reason in each case within 12 months following the Change in Control Date, then the Executive shall be entitled to a lump sum payment in cash, payable within 55 days following the Date of
Termination, of the aggregate of the following amounts: 
 (1) the Accrued Obligations; 

(2) an amount equal to 1.5 times the Executive’s annual base salary then in effect; 

(3) Average Bonus; and 
 (4) a
taxable lump-sum cash payment equal to the Executive’s aggregate premiums to continue his or her existing group health coverage (medical, dental, and vision) in effect as of the Date of Termination for a period of 12 months (which payment shall
be made if the Executive elects such continuation coverage within 55 days following the Date of Termination .). 
 (b)
Termination upon Disability. Subject to the terms and conditions set forth in Sections 4.4 and 5, if the Executive’s employment with the Subsidiary is terminated by reason of the Executive’s Disability, then the Company shall pay the
Executive in a lump sum in cash within 55 days following the Date of Termination, the Accrued Obligations and the Pro-Rata Bonus; provided, however, that the Pro Rata Bonus shall be paid to the Executive no later than March 15th of the calendar
year immediately following the calendar year in which the Executive suffers such Disability or the Executive shall thereafter no longer be eligible to receive such a bonus. 

4.3 Taxes. Notwithstanding any provision of this Agreement to the contrary, if any payment or benefit to be paid or
provided hereunder would be an “Excess Parachute Payment,” within the meaning of Section 280G of the Code, or any successor provision thereto, but for the application of this sentence, then the payments and benefits to be paid or
provided hereunder shall be reduced to the minimum extent necessary (but in no event to less than zero) so that no portion of any such payment or benefit, as so reduced , constitutes an Excess Parachute Payment; provided, however, that the foregoing
reduction shall be made only if and to the extent that such reduction would result in an increase in the aggregate payments and benefits to be provided (i.e. a “best results provision”) determined on an after-tax basis (taking into account
the excise tax imposed pursuant to Section 4999 of the Internal Revenue Code of the United States of America, or any successor provision thereto, any tax imposed by any comparable provision of state law, and any applicable federal, state and
local income taxes). The determination of whether any reduction in such payments or benefits to be provided hereunder is required pursuant to the preceding sentence shall be made by the Company’s independent accountants at the expense of the
Company. The fact that Executive’s right to payments or benefits may be reduced by reason of the limitations contained in this Section shall not of itself limit or otherwise affect any other rights of Executive under this Agreement. In the
event that any payment or benefit intended to be provided hereunder is required to be reduced pursuant to this Section then the payments shall be reduced or eliminated in the following order: (W) any cash payments, (X) any taxable benefits,
(Y) any nontaxable benefits, and (Z) any vesting of equity awards, in each case in reverse order beginning with payments or benefits that are to be paid the farthest in time from the date that triggers the applicability of the excise tax.

  
 -8- 

 4.4 Release. The payment to the Executive (or the Executive’s heirs)
of the amounts and benefits payable under Section 4.2.2 shall be contingent on both (i) the execution by the Executive (or the Executive’s heirs) of the Executive Release and upon the Executive Release becoming effective in accordance
with its terms within 55 days following the Date of Termination, and upon the Executive’s independent legal adviser providing a signed solicitor’s certificate in the form reasonably acceptable to the Company and (ii) agreement by the
Executive to standard confidentiality, a non-solicitation of the customers of the Company and/or the Subsidiary for six-months following the Change in Control and a non-solicitation of any employees of the Company or the Subsidiary for twelve months
following the Change in Control, provided that the Executive signs such agreement by the 55th day following his or her Date of Termination. Executive will be given a 21 day period to review and consider the release (such period may be extended to 45
days if required under applicable law) and the Executive may revoke the release for a period of 7 days, during which time the release shall not become effective or enforceable until the revocation period has expired. 

4.5 Sole Remedy. The payments under this Section 4 constitute the sole remedy of the Executive in the circumstances set
forth in this Section 4. 
 5. Payments Subject to Section 409A. Subject to the provisions in this Section 5, any severance
payments or benefits under this Agreement shall begin only upon the date of the Executive’s "separation from service" (determined as set forth below) which occurs on or after the Section 3 Date of Termination or the Date of Termination, as
applicable. The following rules shall apply with respect to distribution of the payments and benefits, if any, to be provided to the Executive under this Agreement. 

5.1 If, as of the date of the Executive’s “separation from service” from the Subsidiary, the Executive is not a
“specified employee” (within the meaning of Section 409A), then severance payments and benefits shall be made on the dates and terms set forth in this Agreement. 

5.2 If, as of the date of the Executive’s “separation from service” from the Subsidiary, the Executive is a
“specified employee” (within the meaning of Section 409A), then: 
 5.2.1. Each severance payment and benefit due under this
Agreement that, in accordance with the dates and terms set forth herein, will in all circumstances, regardless of when the separation from service occurs, be paid within the short-term deferral period (as defined in Section 409A) shall be
treated as a short-term deferral within the meaning of Treasury Regulation Section 1.409A-l(b)(4) to the maximum extent permissible under Section 409A; and 

  
 -9- 

 5.2.2. Each severance payment and benefit due under this Agreement that is not described in
Section 5.2.1 above and that would, absent this subsection, be paid within the six-month period following the Executive’s “separation from service” from the Subsidiary shall not be paid until the date that is six months and one
day after such separation from service (or, if earlier, the Executive’s death), with any such payments and benefits that are required to be delayed being accumulated during the six-month period and paid in a lump swn on the date that is six
months and one day following the Executive’s separation from service; provided, however, that the preceding provisions of this sentence shall not apply to any severance payments and benefits if and to the maximum extent that any such payment or
benefit is deemed to be paid under a separation pay plan that does not provide for a deferral of compensation by reason of the application of Treasury Regulation 1.409A-l(b)(9)(iii) (relating to separation pay upon an involuntary separation from
service). 
 5.3 The determination of whether and when the Executive’s separation from service from the Subsidiary has
occurred shall be made in a manner consistent with, and based on the presumptions set forth in, Treasury Regulation Section 1.409A-l(h). 

5.4 All reimbursements and in-kind benefits provided under this Agreement shall be made or provided in accordance with the
requirements of Section 409A to the extent that such reimbursements or in-kind benefits are subject to Section 409A, including, where applicable, the requirements that (i) any reimbursement is for expenses incurred during the
Executive’s lifetime (or during a shorter period of time specified in this Agreement), (ii) the amount of expenses eligible for reimbursement during a calendar year may not affect the expenses eligible for reimbursement in any other
calendar year, (iii) the reimbursement of an eligible expense will be made on or before the last day of the calendar year following the year in which the expense is incurred and (iv) the right to reimbursement is not subject to set off or
liquidation or exchange for any other benefit. 
 5.5 Notwithstanding anything herein to the contrary, the Company shall have
no liability to the Executive or to any other person if the payments and benefits provided in this Agreement that are intended to be exempt from or compliant with Section 409A are not so exempt or compliant. 

6. Disputes. 
 6.1
Settlement of Disputes. All claims by the Executive for benefits under Sections 3 and 4 of this Agreement shall be directed to and determined by the Board and shall be in writing. Any denial by the Board of a claim for benefits under this
Agreement shall be delivered to the Executive in writing and shall set forth the specific reasons for the denial and the specific provisions of this Agreement relied upon. The Board shall afford a reasonable opportunity to the Executive for a review
of the decision denying a claim. 

  
 -10- 

 6.2 Expenses. The Company agrees to pay as incurred, to the full extent permitted
by law, all legal , accounting and other fees and expenses which the Executive may reasonably incur as a result of any claim or contest by the Company, the Subsidiary, the Executive or others regarding the validity or enforceability of, or liability
under, Sections 3 and 4 of this Agreement or any guarantee of performance thereof (including as a result of any contest by the Executive regarding the amount of any payment or benefits pursuant to this Agreement); provided that Executive
prevails in the outcome of such claim or contest. 
 6.3 Compensation During a Dispute. Subject to any limitations under
Section 409A, if the Change in Control Date occurs during the Term and the Executive’s employment with the Subsidiary terminates within 12 months following the Change in Control Date, and the right of the Executive to receive benefits
under Section 4 (or the amount or nature of the benefits to which Executive is entitled to receive) are the subject of a dispute between the Company and/or the Subsidiary and the Executive, the Subsidiary shall continue (a) to pay
Executive, the Executive’s base salary in effect as of the Measurement Date and (b) to provide benefits to the Executive and the Executive’s family at least equal to those which would have been provided to them, if the
Executive’s employment had not been terminated, in accordance with the applicable Benefit Plans in effect on the Measurement Date, until such dispute is resolved either by mutual written agreement of the parties or by final adjudication.
Following the resolution of such dispute, the sum of the payments made to the Executive under clause (a) of this Section 6.3 shall be deducted from any cash payment which the Executive is entitled to receive pursuant to Section 4, if
any; and if such sum exceeds the amount of the cash payment which the Executive is entitled to receive pursuant to Section 4, if any, the excess of such sum over the amount of such payment shall be repaid (without interest) by the Executive to
the Company within 60 days of the resolution of such dispute. 
 7. Successors. 

7.1 Successor to Company. The Company shall require any successor (whether direct or indirect, by purchase, merger,
consolidation or otherwise) to all or substantially all of the business or assets of the Company expressly to assume and agree to perform this Agreement to the same extent that the Company would be required to perform it if no such succession had
taken place, provided that: (i) nothing in this Agreement shall oblige any successor to pay any further sums to the Executive in the event that the Company and the Subsidiary have fulfilled their respective obligations to make payments
to the Executive and/or the Agreement expires due to any other term set forth in Section 2 above; and (ii) the successor shall not be entitled to ignore the occurrence of a Change in Control in order to avoid any obligations under this
Agreement. Failure of the Company to obtain an assumption of this Agreement at or prior to the effectiveness of any succession shall be a breach of this Agreement and shall constitute Good Reason if the Executive elects to terminate employment As
used in this Agreement, “Company” shall mean the Company as defined above and any successor to its business or assets as aforesaid which assumes and agrees to perform this Agreement, by operation of law or otherwise. 

  
 -11- 

 7.2 Successor to Executive. This Agreement shall inure to the benefit of
and be enforceable by the Executive’s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees. If the Executive should die while any amount would still be payable to the Executive or
Executive’s family hereunder if the Executive had continued to live, all such amounts, unless otherwise provided herein, shall be paid in accordance with the terms of this Agreement to the executors, personal representatives or administrators
of the Executive’s estate. 
 8. Notice. All notices, instructions and other communications given hereunder or in connection
herewith shall be in writing. Any such notice, instruction or communication shall be sent either (i) by registered or certified mail, return receipt requested, postage prepaid, or (ii) prepaid via a reputable nationwide overnight courier
service, in each case addressed to the Company or the Subsidiary, both at 2584 Junction Avenue, San Jose, CA 95134, Attn: General Counsel, and to the Executive at the Executive’s address indicated on the signature page of this Agreement (or to
such other address as either the Company or the Executive may have furnished to the other in writing in accordance herewith). Any such notice, instruction or communication shall be deemed to have been delivered .five business days after it is sent
by registered or certified mail, return receipt requested, postage prepaid, or one business day after it is sent via a reputable nationwide overnight courier service. Either party may give any notice, instruction or other communication hereunder
using any other means, but no such notice, instruction or other communication shall be deemed to have been duly delivered unless and until it actually is received by the party for whom it is intended. 

9. Miscellaneous. 

9.1 Employment by Subsidiary. For purposes of this Agreement, the Executive’s employment with the Subsidiary shall
not be deemed to have terminated solely as a result of the Executive continuing to be employed by the Company itself or another wholly-owned subsidiary of the Company. 

9.2 Severability. The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or
enforceability of any other provision of this Agreement, which shall remain in full force and effect 
 9.3 Injunctive
Relief. The Company and the Executive agree that any breach of this Agreement by the Company or the Subsidiary is likely to cause the Executive substantial and irrevocable damage and therefore, in the event of any such breach, in addition to
such other remedies which may be available, the Executive shall have the right to specific performance and injunctive relief. 

9.4 Exclusive Severance Benefits. The making of the payments and the provision of the benefits by the Subsidiary and/or
the Company to the Executive under this Agreement shall constitute the entire obligation of the Subsidiary and the Company respectively to the Executive as a result of the termination of Executive’s employment, and the Executive shall not be
entitled to additional payments or benefits as a result of such termination of employment under any other plan, program, policy, practice, contract or agreement of the Company, the Subsidiary or their respective subsidiaries. In particular, the
payments made by the Company and/or the Subsidiary to the Executive under this Agreement shall be deemed by the parties to include any redundancy payments (whether statutory or otherwise), and any payment in lieu of notice or damages for wrongful
dismissal that may otherwise have been due. Hence, no additional redundancy payment, payment in lieu of notice or damages for wrongful dismissal shall be owed to the Executive in these circumstances. 

  
 -12- 

 9.5 Mitigation. The Executive shall not be required to mitigate the amount of any
payment or benefits provided for in Sections 3.1 and 4.2.2 by seeking other employment or otherwise. Further, the amount of any payment or benefits provided for in this Agreement shall not be reduced by any compensation earned by the Executive as a
result of employment by another employer, by retirement benefits, by offset against any amount claimed to be owed by the Executive to the Company or the Subsidiary or otherwise. 

9.6 Not an Employment Contract. The Executive acknowledges that this Agreement does not constitute a contract of employment or
impose on the Company or the Subsidiary any obligation to retain the Executive as an employee and that this Agreement does not prevent the Executive from terminating employment at any time. If the Executive’s employment with the Subsidiary
terminates for any reason and subsequently a Change in Control shall occur, the Executive shall not be entitled to any benefits hereunder except as otherwise provided pursuant to Section 3 or 4. 

9.7 Governing Law. The validity, interpretation, construction and performance of this Agreement shall be governed by the
internal laws of the State of Delaware, without regard to conflicts of law principles. 
 9.8 Waivers. No waiver by
the Executive at any time of any breach of, or compliance with, any provision of this Agreement to be performed by the Company or the Subsidiary shall be deemed a waiver of that or any other provision at any subsequent time. 

9.9 Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed to be an original but
both of which together shall constitute one and the same instrument. 
 9.10 Tax Withholding. Any payments provided for
hereunder shall be paid net of any applicable tax withholding required under federal, state or local law. 
 9.11 Entire
Agreement. This Agreement sets forth the entire agreement of the parties hereto in respect of the subject matter contained herein and supersedes all prior agreements, promises, covenants, arrangements, communications, representations or warranties,
whether oral or written, by any officer, employee or representative of any party hereto in respect of the subject matter contained herein; and any prior agreement of the parties hereto in respect of the subject matter contained herein is hereby
terminated and cancelled. 
 9.12 Amendments . This Agreement may be amended or modified only by a written instrument
executed by both the Company and the Executive. 

  
 -13- 

 9.13 Executive’s Acknowledgements. The Executive acknowledges that
Executive: (a) has read this Agreement; (b) has been represented in the preparation, negotiation, and execution of this Agreement by legal counsel of the Executive’s own choice or has voluntarily declined to seek such counsel; and
(c) understands the terms and consequences of this Agreement; and (d) understands that by executing this Agreement, the Employee forever waives and forfeits all rights under any prior agreements relating to the subject matter herein. 

  
 -14- 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first
set forth above. 
  

			
	OCLARO, INC.
		
	 By:
	 	 /s/ GREG DOUGHERTY

		 	Greg Dougherty
	Title:	 	CEO
	
	 OCLARO TECHNOLOGY LIMITED
  

	By:	 	/s/ ELAINE BARNDEN
		 	Elaine Barnden
	 Title:
	 	Senior Director HR, EMEA
		
		 	
	
	 The Executive
  

	
	/s/ ADRIAN MELDRUM
	Adrian Meldrum
	
	 Address:
  

71 Bishops Drive,
 Wokingham,

Berks
 RG40 lWA

  
 -15-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00226-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00226-of-00352.parquet"}]]